Litcius/Paper detail

Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan

Masaaki Niino, Noriko Isobe, M. Araki, Takashi Ohashi, Tomoko Okamoto, Mieko Ogino, Tatsusada Okuno, Hirofumi Ochi, Izumi Kawachi, Yuko Shimizu, Kazuya Takahashi, Hideyuki Takeuchi, Masayuki Tahara, Norio Chihara, Ichiro Nakashima, Hikoaki Fukaura, Tatsuro Misu, Yusei Miyazaki, Katsuichi Miyamoto, Masahiro Mori, Makoto Kinoshita, Yoshiki Takai, Chihiro Fujii, Mitsuru Watanabe, Kazuo Fujihara

2024Multiple Sclerosis and Related Disorders23 citationsDOI

Topics & Concepts

Neuromyelitis opticaMyelin oligodendrocyte glycoproteinMultiple sclerosisMedicineSpectrum disorderOligodendrocyteDiseaseMyelinAntibodyImmunologyPathologyCentral nervous systemInternal medicinePsychiatryExperimental autoimmune encephalomyelitisMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersClinical practice guidelines implementation
Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease 2023 in Japan | Litcius